November 2009

Vol. 21. No. 4


Autism spectrum disorders: Rising prevalence drives research on causes and cures

Sanjay Gupta, MD | Daniel A. Rossignol, MD, FAAFP

This special issue of Annals of Clinical Psychiatry features original research and review articles on autism spectrum disorders (ASD) as a continuation of our August issue. A recent survey reports a higher prevalence of ASD in the United States—1.1% or 1 in 91 children age 3 to 17—than previously estimated.1 The survey also reports that nearly 40% of children who had been diagnosed with ASD did not currently have the condition. These results reinforce the importance of early recognition and effective interventions for children with ASD.



Retrospective analysis of clinical records in 38 cases of recovery from autism

Doreen Granpeesheh, PhD, BCBA | Edward Carr, PhD | Martha Herbert, PhD

Background: Twenty years of research on early intensive treatment using applied behavior analysis (ABA) for children with autism has consistently produced robust effects. There appears to be a subset of children whose response to intensive ABA treatments includes achieving a level of functioning that is indistinguishable from typically developing peers. The purpose of this study was to describe a subset of children who recovered from autism following intensive ABA interventions.



Novel and emerging treatments for autism spectrum disorders: A systematic review

Daniel A. Rossignol, MD, FAAFP

Background: Currently, only one medication (risperidone) is FDA- approved for the treatment of autism spectrum disorders (ASD). Perhaps for this reason, the use of novel, unconventional, and off-label treatments for ASD is common, with up to 74% of children with ASD using these treatments; however, treating physicians are often unaware of this usage.